Understanding OUR Cytokine-Based Immunotherapy Candidates Our dedication extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, specifically for cancers where cure solutions remain limited. Utilize the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Explore Our Pipeline We https://financefeeds.com/ryu-hirayama-joins-lseg-as-country-representative-for-japan/